KIRSTEN MANALO: Open Payments
NPI 1497381651 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$80 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $745 · 2025 $80
Food & beverage: $80
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Neuronetics, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: FANAPT, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
